Skip To Content
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.
Before it's here, it's on the Bloomberg Terminal.
Learn More
ALNA:USNASDAQ GS

Allena Pharmaceuticals Inc

COMPANY INFO
3.82USD
+0.02+0.53%
Market Closed
As of 08/16/2019 EDT
Open
3.82
Prev Close
3.80
Volume
32,688
Market Cap
89.639M
Day Range
3.794.00
52 Week Range
3.6212.00
1D1M1Y5Y
View Full Chart
Market Closed
As of 08/16/2019 EDT
1D1M1Y5Y
View Full Chart
markets
Walmart Jumps Most in a Year on Strong 2Q Sales
Before it's here, it's on the Bloomberg Terminal.
Learn More
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.

Key Statistics

P/E Ratio--
Bloomberg (BEst) P/E Ratio--
Bloomberg (BEst) PEG Ratio--
Shares Outstanding23.47M
Price to Book Ratio2.3790
Price to Sales Ratio--
1 Year Return-64.06%
30 Day Avg Volume68,210
EPS-2.01
Bloomberg (BEst) EPS Curr Yr-1.9810
Dividend--
Last Dividend Reported--
Earnings Announcement for Period Ending Q3/2019:11/05/2019

Compare
1-Day Performance

0+2%
0+2%
Equity
ALNA:US
+0.53%
Sponsored By

About Allena Pharmaceuticals Inc

Allena Pharmaceuticals, Inc. operates as a bio-pharmaceutical company. The Company develops oral enzyme therapeutics and focuses on treating metabolic and orphan diseases such as oxalate and urate. Allena Pharmaceuticals serves patients in the United States.
Address
1 Newton Executive Park Suite 202 Newton, MA 02462 United States
Phone
1-617-467-4577
Website
www.allenapharma.com

Income Statement

Quarterly
Annual
Q3 2019 (Millions USD)
  • Revenue
    --
  • Net Income
    -11,273,000.00
  • Profit Margin
    --%

Balance Sheet

Quarterly
Annual
;
Q2 2019 (Millions USD)
  • Total Assets
    53.58
  • Total Liabilities
    15.91
  • Debt to Assets
    20.03%

Cash Flow

Quarterly
Annual
Q2 2019 (Millions USD)
  • Operating
    -12.83
  • Investing
    -0.02
  • Financing
    9.61